Novogene is a pioneer in applying cutting-edge molecular biology technology and high-performance computing to research in the fields of life science and human health. Novogene has extensive coverage in global genome projects and has accumulated vast experiences in third-generation library preparation, sequencing, and bioinformatics analysis for numerous species. Novogene has technical advantages in de novo sequencing technology and applications, holding 18 patent licenses and over 40 software copyrights. Our vision is to be the global leader in providing genomic services and solutions.